Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Early Hours Recap on EXC, WCRX, MDT and DNDN Note to Editors: The Following Is an Investment Opinion Being Issued by the WSA Financial Ltd.


Print article Print article
© Marketwire 2013
2013-02-25 16:09:30 -

LONDON -- (Marketwire) -- 02/25/13 -- On Friday, the S&P 500 still finished lower for the week, the index's first weekly loss in 2013. The Dow Jones finished 0.86% higher at 14,000.57, the S&P 500 finished 0.88% higher at 1,515.60, and the NASDAQ finished 0.97% higher at 3,161.82. At the close, our research team took notice of Exelon Corporation (NYSE: EXC), Warner Chilcottplc (NASDAQ: WCRX), Medtronic Inc. (NYSE: MDT) and Dendreon Corp. (NASDAQ: DNDN). WallStreetActive research team has completed free research on EXC, WCRX, MDT and DNDN, we invite you to sign up now at





http://www.wallstreetactive.com/register.php : ctt.marketwire.com/?release=989746&id=2661925&type=1& ..



Exelon is currently trading at $30.49, up 0.29 cents which corresponds to a 0.96% upward movement from its last close. The stock has a beta of 0.5. The stock is trading in the range of $30.21 - $30.72. The stock has a 52-week low of $28.40 and a 52-week high of $39.95. The stock traded a volume of 6,990,760 at the end of Friday's session. It has a 3-month average volume of 8,282,340. Sign up today and get useful insight about EXC for free at



http://www.wallstreetactive.com/register.php : ctt.marketwire.com/?release=989746&id=2661928&type=1& ..



Warner Chilcott is currently trading at $13.96, up 0.20 cents which corresponds to a 1.45% upward movement from its last close. The stock has a beta of 1.29. The stock is trading in the range of $13.64 - $14.25. The stock has a 52-week low of $10.85 and a 52-week high of $23.28. The stock traded a volume of 3,739,319 at the end of Friday's session. It has a 3-month average volume of 5,064,840. Free report on WCRX can be accessed by registering at



http://www.wallstreetactive.com/register.php : ctt.marketwire.com/?release=989746&id=2661931&type=1& ..



Medtronic is currently trading at $44.72, down 0.01 cents which corresponds to a 0.02% downward movement from its last close. The stock has a beta of 1. The stock is trading in the range of $44.55 - $45.08. The stock has a 52-week low of $35.67 and a 52-week high of $47.40. The stock traded a volume of 4,313,040 at the end of Friday's session. It has a 3-month average volume of 4,492,940. Register with WallStreetActive.com and download the research on MDT for free at



http://www.wallstreetactive.com/register.php : ctt.marketwire.com/?release=989746&id=2661934&type=1& ..



Dendreon is currently trading at $5.67, down 0.09 cents which corresponds to a 1.56% downward movement from its last close. The stock has a beta of 3. The stock is trading in the range of $5.61 - $5.90. The stock has a 52-week low of $3.69 and a 52-week high of $13.89. The stock traded a volume of 4,290,535 at the end of Friday's session. It has a 3-month average volume of 6,300,820. Read the full free research on DNDN by signing up to Wall Street Active at



http://www.wallstreetactive.com/register.php : ctt.marketwire.com/?release=989746&id=2661937&type=1& ..



Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.




Contact Person:
Ravi S. Kapur
Telecommunication, Information & Data Manager
info@wallstreetactive.com :



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser